Overview

Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study

Status:
Not yet recruiting
Trial end date:
2025-09-20
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of microwave ablation combined with Camrelizumab and chemotherapy in the treatment of patients with advanced non-small cell lung cancer.
Phase:
N/A
Details
Lead Sponsor:
Henan Provincial People's Hospital